Megakaryocytes are the parent cells that make platelets—sticky bodies that circulate in the bloodstream and help the blood to clot when you get cut. They are also the culprits that contribute to clot ...

In addition to enabling the manufacture of platelets on demand, the finding could help doctors better treat both cancer and thrombocytopenia, a clotting disorder that often strikes newborns in ...

Using a special microscopy technique, scientists have learned that the lungs have a role in the production of blood. With video of a live mouse lung, they revealed that the lungs produce more than ...

This section presents medications that are known to potentially lead to 'Platelet production decreased' as a side effect. It's important to note that mild side effects are quite common with ...

You must have heard platelet count decreasing in diseases like dengue or viral infections. But do you know what it is and its role in your overall health? These are small colourless cell fragments in ...

Humans produce billions of clot-forming platelets every day, but there are times when there aren't enough of them, such as with certain diseases or during invasive surgery. Now, researchers have ...

Platelets are uniquely mammalian cells, and are the small cells of the blood that are critical for us to stop bleeding when we cut ourselves. They are also a central part of the process of thrombosis, ...

Attacking a platelet-depleting autoimmune disease in a whole new way, an experimental drug is helping patients with immune thrombocytopenic purpura (ITP) once again produce healthy amounts of ...

Incorporation of intravenously injected ⁷⁵Se selenomethionine into platelets has been found to vary with alterations in the rate of platelet production. It appears to label newly produced platelets ...

A blood disorder called thrombocytopenia can cause uncontrollable bleeding in sufferers, thanks to a shortage of platelets - the blood cells that are involved in the job of clotting in damaged vessels ...

A new discovery from the University of Virginia School of Medicine could let doctors ramp up production of blood-clotting platelets on demand, a timely finding following the Red Cross’ declaration ...